Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion type Assertion NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_head.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion description "[Genetic polymorphisms in genes related to metabolism and action sites of gemcitabine showed associations with the therapeutic efficacy, in terms of OS, TTP and disease progression in pancreatic cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_provenance.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion evidence source_evidence_literature NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_provenance.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion SIO_000772 22838950 NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_provenance.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion wasDerivedFrom befree-20140225 NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_provenance.
- NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_assertion wasGeneratedBy ECO_0000203 NP158563.RAR6y9HcAAVAU0tLaHOs3151CjTWH4C4jf-wR8bZjCLnc130_provenance.